Vivus asks U.S. experts to back its obesity drug (Reuters)

[unable to retrieve full-text content]Reuters - Proponents of a new obesity medication from Vivus Inc told U.S. reviewers on Wednesday that the drug's health benefits exceed heart and birth defect risks.

Source: http://us.rd.yahoo.com/dailynews/rss/weightloss/*http%3A//news.yahoo.com/s/nm/20120222/hl_nm/us_fda_obesity_vivus

ben gazzara nfl hall of fame 2012 ufc diaz vs condit josephine baker askew super bowl start time target jason wu